GE Medical
This article was originally published in The Gray Sheet
Executive Summary
Shareholders of Madison, Wisconsin-based Lunar Corp. will receive 0.322 shares of GE stock for each share of Lunar stock under terms of the firms' merger deal completed Aug. 8. Announced June 2, the agreement was valued at roughly $144 mil. A manufacturer of diagnostics for osteoporosis and metabolic bone disease as well as orthopedic surgery devices, Lunar will add $91 mil. in annual revenues to GE's $7 bil. Medical Systems business. GEMS hopes to accelerate Lunar's top-line growth above the single-digit pace of the overall bone densitometry market (1"The Gray Sheet" June 5, p. 13)